Vaxart, Inc. Gain (Loss) on Disposition of Assets
Vaxart, Inc. (VXRT) reported Gain (Loss) on Disposition of Assets of -$2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-06
- Vaxart, Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $8.00K.
- Vaxart, Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was -$10.00K.
- Vaxart, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was -$33.00K.
- Vaxart, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was -$5.00K.
- Vaxart, Inc. gain (loss) on disposition of assets for fiscal 2023 was -$55.00K.
- Vaxart, Inc. gain (loss) on disposition of assets for fiscal 2015 was -$200.00K.
- Vaxart, Inc. gain (loss) on disposition of assets for fiscal 2011 was -$100.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.00K derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | -$2.00K 10-Q · filed 2026-08-06 | -$35.00K derived: sum of 3 quarters · filed 2026-08-06 | -$40.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$10.00K S-1 · filed 2026-05-08 | -$43.00K derived: sum of 2 quarters · filed 2026-05-08 | -$48.00K derived: sum of 3 quarters · filed 2026-05-08 | -$48.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$33.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | -$38.00K derived: sum of 2 quarters · filed 2026-05-08 | -$38.00K derived: sum of 3 quarters · filed 2026-08-06 | -$38.00K S-1 · filed 2026-05-08 |
| 2025-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$5.00K derived: sum of 2 quarters · filed 2026-08-06 | -$5.00K 10-Q · filed 2025-11-13 | -$5.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 S-1 · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $0.00 derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $0.00 S-1 · filed 2026-05-08 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | -$55.00K 10-K · filed 2025-03-20 | |||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$200.00K derived: sum of 2 quarters · filed 2016-09-13 | -$200.00K 10-K · filed 2016-09-13 | |
| 2015-03-31 | -$200.00K 10-Q · filed 2016-05-10 | -$200.00K 10-Q · filed 2016-05-10 | ||
| 2011-06-30 | -$100.00K 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |